Joint (NASDAQ:JYNT) Announces Earnings Results, Beats Expectations By $0.01 EPS

Joint (NASDAQ:JYNT) posted its earnings results on Thursday. The company reported $0.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.03 by $0.01, Fidelity Earnings reports. The firm had revenue of $12.73 million during the quarter, compared to the consensus estimate of $11.60 million. Joint had a net margin of 5.38% and a return on equity of 114.93%.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

NASDAQ JYNT traded down $0.66 on Friday, reaching $19.15. The company had a trading volume of 459,700 shares, compared to its average volume of 155,324. Joint has a 1 year low of $6.51 and a 1 year high of $21.80. The company has a debt-to-equity ratio of 3.33, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a 50-day moving average of $18.82 and a 200-day moving average of $18.09. The firm has a market capitalization of $275.64 million, a PE ratio of 478.75 and a beta of 1.01.

A number of analysts recently issued reports on JYNT shares. Zacks Investment Research raised shares of Joint from a “hold” rating to a “buy” rating and set a $23.00 target price for the company in a research report on Wednesday, October 30th. TheStreet downgraded shares of Joint from a “b-” rating to a “c” rating in a research report on Tuesday, September 3rd. BidaskClub raised shares of Joint from a “buy” rating to a “strong-buy” rating in a research report on Thursday, September 19th. B. Riley set a $23.00 target price on shares of Joint and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, DA Davidson reissued a “buy” rating on shares of Joint in a research report on Monday, November 4th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $24.17.

Joint Company Profile

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States.

Recommended Story: Economic Reports

Earnings History for Joint (NASDAQ:JYNT)

Leave a Reply

Your email address will not be published. Required fields are marked *

*